Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Storr

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Gastroenterology|October 26, 2010
Reflux disease as a motility disorder: treatment alternatives to acid suppressionMartin Storr, Hans-Dieter Allescher
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2008
Medical management of irritable bowel syndrome in 2008: current and future directionsMartin Storr, Christopher N Andrews
Pain|August 12, 2014
Cross-talk between serotonin and cannabinoid signaling in the gut, new insights and future perspectivesMaciej Salaga, Martin Storr, Jakub Fichna
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Carina Hasenoehrl, Martin Storr, Rudolf Schicho
Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tractFederico Massa, Martin Storr, Beat Lutz
Current Drug Targets|February 3, 2015
Cardiovascular complications in inflammatory bowel diseaseRudolf Schicho, Gunther Marsche, Martin Storr
Clinical and Translational Gastroenterology|January 4, 2020
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel DiseasesMelanie Kienzl, Martin Storr, Rudolf Schicho
Pharmacology|July 4, 2015
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An OverviewTheodor Bokic, Martin Storr, Rudolf Schicho
Therapeutic Advances in Gastroenterology|September 2, 2015
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectivePaula Mosińska, Martin Storr, Jakub Fichna
World Journal of Gastroenterology|July 4, 2015
Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipationPaula Mosińska, Jakub Fichna, Martin Storr
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Gastroenterology|October 26, 2010
Reflux disease as a motility disorder: treatment alternatives to acid suppressionMartin Storr, Hans-Dieter Allescher
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 15, 2008
Medical management of irritable bowel syndrome in 2008: current and future directionsMartin Storr, Christopher N Andrews
Pain|August 12, 2014
Cross-talk between serotonin and cannabinoid signaling in the gut, new insights and future perspectivesMaciej Salaga, Martin Storr, Jakub Fichna
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Carina Hasenoehrl, Martin Storr, Rudolf Schicho
Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tractFederico Massa, Martin Storr, Beat Lutz
Current Drug Targets|February 3, 2015
Cardiovascular complications in inflammatory bowel diseaseRudolf Schicho, Gunther Marsche, Martin Storr
Clinical and Translational Gastroenterology|January 4, 2020
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel DiseasesMelanie Kienzl, Martin Storr, Rudolf Schicho
Pharmacology|July 4, 2015
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An OverviewTheodor Bokic, Martin Storr, Rudolf Schicho
Therapeutic Advances in Gastroenterology|September 2, 2015
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectivePaula Mosińska, Martin Storr, Jakub Fichna
World Journal of Gastroenterology|July 4, 2015
Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipationPaula Mosińska, Jakub Fichna, Martin Storr
Pageof 16